Loss of smell (anosmia or olfactory dysfunction) is an early warning sign of Alzheimer's disease.
NOT BSTOTAL BS
SOME BS — Verdict: Mixed
Verified by Lenz ·
The Short Version
Research consistently links olfactory decline to Alzheimer's-related biomarkers and future dementia risk, but the claim's framing overstates the connection. Smell loss is extremely common in normal aging, Parkinson's disease, Lewy body dementia, and many non-neurological conditions, making it far too nonspecific to serve as an Alzheimer's-specific warning sign. Major clinical authorities including the WHO and Mayo Clinic do not list it among primary early Alzheimer's symptoms. The evidence supports smell loss as a population-level risk indicator, not a reliable individual warning sign for Alzheimer's in particular.
Caveats
Olfactory dysfunction is common in normal aging and many other conditions — including Parkinson's disease, Lewy body dementia, nasal disorders, and post-viral syndromes — so smell loss alone cannot point specifically to Alzheimer's.
The evidence supports smell loss as a statistical risk marker in research populations, not as a clinically reliable standalone early warning sign for any individual.
Major clinical guidelines (WHO, Mayo Clinic) do not list smell loss among primary early symptoms of Alzheimer's disease, reflecting its limited diagnostic utility in practice.